GBA1 and Parkinson disease: Further research has focused on the differential effect of mild versus severe pathogenic variants in GBA1, and it has been established that severe variants (e.g., 84insG) increased the risk of developing PD by ~15-fold while mild pathogenic variants (e.g., N370S) increased the risk of developing PD by ~3-fold [8].